We are live on !
Find out more
SC
Schulhoff & Co Portfolio holdings
AUM
$249M
Turnover
3.68%
1-Year Est. Return
25.29%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+25.29%
3 Year Est. Return
+51.82%
5 Year Est. Return
+66.94%
10 Year Est. Return
+187.74%
AUM
$240M
AUM Growth
+$17.9M
(+8.1%)
Cap. Flow
+$568K
Cap. Flow % of AUM
Cap. Flow %
0.24%
Top 10 Holdings %
Top 10 Hldgs %
43.93%
Holding
131
New
5
Increased
34
Reduced
37
Closed
3
Avg Time Held
7.5
years
Top 10 Avg Time Held
5.5
years
Top 20 Avg Time Held
7.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pyxis Oncology
PYXS
|
+$280K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$232K |
| 3 |
Johnson Controls International
JCI
|
+$202K |
| 4 |
Lamar Advertising Co
LAMR
|
+$198K |
| 5 |
Diageo
DEO
|
+$196K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$264K |
| 2 |
Pfizer
PFE
|
+$229K |
| 3 |
Vanda Pharmaceuticals
VNDA
|
+$218K |
| 4 |
Hillenbrand
HI
|
+$200K |
| 5 |
Walt Disney
DIS
|
+$114K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 26.49% |
| 2 | Financials | 16.59% |
| 3 | Industrials | 12.75% |
| 4 | Healthcare | 11.19% |
| 5 | Technology | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Procter & Gamble
PG
$387B
| $38.5M | 16.08% |
222,412
-387
| -0.2% | -$65.7K |
2013 Q2
45 quarters
|
|
2
JPMorgan Chase
JPM
$896B
| $9.7M | 4.06% |
46,156
+15
| +0% | +$3.16K |
2013 Q2
45 quarters
|
|
3
Lockheed Martin
LMT
$133B
| $9.34M | 3.9% |
15,975
+7
| +0% | +$3.76K |
2013 Q2
45 quarters
|
|
4
ExxonMobil
XOM
$674B
| $9.28M | 3.87% |
79,165
+496
| +0.6% | +$57.3K |
2013 Q2
45 quarters
|
|
5
Berkshire Hathaway Class A
BRK.A
$1.22T
| $7.6M | 3.17% |
11
| – | – |
2013 Q2
45 quarters
|
|
6
Cincinnati Financial
CINF
$28.9B
| $7.25M | 3.03% |
53,287
+42
| +0.1% | +$5.43K |
2013 Q2
45 quarters
|
|
7
Johnson & Johnson
JNJ
$656B
| $7.06M | 2.95% |
43,583
+84
| +0.2% | +$13.4K |
2013 Q2
45 quarters
|
|
8
Coca-Cola
KO
$412B
| $5.51M | 2.3% |
76,702
-209
| -0.3% | -$14.3K |
2013 Q2
45 quarters
|
|
9
AbbVie
ABBV
$509B
| $5.49M | 2.29% |
27,818
-85
| -0.3% | -$15.9K |
2013 Q2
45 quarters
|
|
10
Chevron
CVX
$415B
| $5.41M | 2.26% |
36,752
+236
| +0.6% | +$35.1K |
2013 Q2
45 quarters
|
|
11
Microsoft
MSFT
$3.98T
| $5.06M | 2.11% |
11,755
-85
| -0.7% | -$36.3K |
2013 Q2
45 quarters
|
|
12
Accenture
ACN
$162B
| $4.59M | 1.92% |
12,980
+424
| +3% | +$139K |
2013 Q2
45 quarters
|
|
13
US Bancorp
USB
$93.1B
| $4.34M | 1.81% |
94,962
-545
| -0.6% | -$23.9K |
2013 Q2
45 quarters
|
|
14
Eli Lilly
LLY
$1.22T
| $4.31M | 1.8% |
4,860
-20
| -0.4% | -$18K |
2013 Q2
45 quarters
|
|
15
Apple
AAPL
$5.02T
| $4.3M | 1.8% |
18,468
-495
| -3% | -$111K |
2022 Q4
7 quarters
|
|
16
Mid-America Apartment Communities
MAA
$14.1B
| $4.01M | 1.67% |
25,207
-120
| -0.5% | -$18.3K |
2013 Q2
45 quarters
|
|
17
PepsiCo
PEP
$194B
| $3.76M | 1.57% |
22,098
-96
| -0.4% | -$16.5K |
2013 Q2
45 quarters
|
|
18
ScottsMiracle-Gro
SMG
$3.86B
| $3.61M | 1.51% |
41,673
-315
| -0.8% | -$22.1K |
2013 Q2
45 quarters
|
|
19
General Dynamics
GD
$96.3B
| $3.47M | 1.45% |
11,471
+1
| +0% | +$294 |
2013 Q3
44 quarters
|
|
20
United Parcel Service
UPS
$94.5B
| $3.18M | 1.33% |
23,357
-67
| -0.3% | -$8.8K |
2013 Q2
45 quarters
|
|
21
Mondelez International
MDLZ
$84.6B
| $2.55M | 1.06% |
34,318
+50
| +0.1% | +$3.51K |
2013 Q2
45 quarters
|
|
22
Qualcomm
QCOM
$167B
| $2.51M | 1.05% |
14,763
+225
| +2% | +$39.7K |
2013 Q2
45 quarters
|
|
23
Emerson Electric
EMR
$90.7B
| $2.51M | 1.05% |
22,925
+3
| +0% | +$323 |
2013 Q2
45 quarters
|
|
24
IBM
IBM
$234B
| $2.35M | 0.98% |
10,649
| – | – |
2013 Q2
45 quarters
|
|
25
PNC Financial Services
PNC
$90.5B
| $2.12M | 0.88% |
11,464
+2
| +0% | +$351 |
2013 Q2
45 quarters
|
|
Similar funds
RSC
VM
Schulhoff & Co's Q3 2024 Portfolio in Review
As of Q3 2024, Schulhoff & Co held 131 positions worth $240M, up 8.1% from $222M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Schulhoff & Co's Q3 2024 filing shows 5 new, 34 increased, 37 reduced and 3 closed positions. Its largest new stake was Johnson Controls International: 2,873 shares worth $223K. The largest sale was Edwards Lifesciences, an estimated $264K.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
- Schulhoff & Co's largest Q3 2024 buy was Johnson Controls International: 2,873 shares worth $223K.
- Schulhoff & Co added most to Pyxis Oncology in Q3 2024, an estimated $280K increase.
- Schulhoff & Co's biggest Q3 2024 reduction was Pfizer, cutting an estimated $229K.
- Schulhoff & Co fully exited Edwards Lifesciences in Q3 2024, selling an estimated $264K.
- Schulhoff & Co's ten largest holdings make up 44% of its $240M portfolio in Q3 2024.
- Schulhoff & Co opened 5 new positions and closed 3 in Q3 2024.
- Schulhoff & Co's portfolio value rose 8.1% quarter-over-quarter to $240M.
Based on Schulhoff & Co's 13F filing for Q3 2024, filed 6 Nov 2024.